4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000221
Chief Executive Officer sold 203,814 shares at an average $60.32 ($12,294,703)
- Chief Executive Officer acquired 203,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Monia Brett P · Chief Executive Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-03 | Exercise or conversion : show line 1 in the form | +102,900 | $53.77 | $5,532,933 | 282,909 | D |
| 2025-09-03 | Sale : show line 2 in the form | −16,615 | $59.12 | $982,262 | 266,294 | D |
| 2025-09-03 | Exercise or conversion : show line 3 in the form | +42,030 | $37.58 | $1,579,487 | 308,324 | D |
| 2025-09-03 | Sale : show line 4 in the form | −127,500 | $60.13 | $7,667,047 | 180,824 | D |
| 2025-09-03 | Exercise or conversion : show line 5 in the form | +31,316 | $32.60 | $1,020,902 | 212,140 | D |
| 2025-09-03 | Exercise or conversion : show line 6 in the form | +27,568 | $32.60 | $898,717 | 239,708 | D |
| 2025-09-03 | Sale : show line 7 in the form | −59,699 | $61.06 | $3,645,394 | 180,009 | D |
| Open-market sales · 203,814 sh · avg $60.32 · $12,294,703 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-03 | Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) | −31,316 | 67,741 | D |
| 2025-09-03 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | −27,568 | 40,173 | D |
| 2025-09-03 | Exercise or conversion : show line 10 in the form Non-Qualified Stock Option (right to buy) | −42,030 | 76,643 | D |
| 2025-09-03 | Exercise or conversion : show line 11 in the form Non-Qualified Stock Option (right to buy) | −102,900 | 0 | D |
Loading xslF345X05/edgardoc.xml…